Page last updated: 2024-11-04

sulfadiazine and Aura

sulfadiazine has been researched along with Aura in 1 studies

Sulfadiazine: One of the short-acting SULFONAMIDES used in combination with PYRIMETHAMINE to treat toxoplasmosis in patients with acquired immunodeficiency syndrome and in newborns with congenital infections.
sulfadiazine : A sulfonamide consisting of pyrimidine with a 4-aminobenzenesulfonamido group at the 2-position.
diazine : The parent structure of the diazines.

Research Excerpts

ExcerptRelevanceReference
"A treatment with valproic acid was started, obtaining control of the neurological disease."1.43Recurrent seizures during acute acquired toxoplasmosis in an immunocompetent traveller returning from Africa. ( Bassetti, M; Beltrame, A; Buonfrate, D; Crichiutti, G; Meroni, V; Venturini, S, 2016)

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Beltrame, A1
Venturini, S1
Crichiutti, G1
Meroni, V1
Buonfrate, D1
Bassetti, M1

Other Studies

1 other study available for sulfadiazine and Aura

ArticleYear
Recurrent seizures during acute acquired toxoplasmosis in an immunocompetent traveller returning from Africa.
    Infection, 2016, Volume: 44, Issue:2

    Topics: Adolescent; Antibodies, Protozoan; Anticonvulsants; Antiprotozoal Agents; Epilepsy; Ethiopia; Humans

2016